| Anebulo Pharmaceuticals, Inc. | |||||||||||||||||||||||||||||||||||||||||||||||||
| Q4-CY2025 | Q3-CY2025 | Q2-CY2025 | Q1-CY2025 | Q4-CY2024 | Q3-CY2024 | Q2-CY2024 | Q1-CY2024 | Q4-CY2023 | Q3-CY2023 | Q2-CY2023 | Q1-CY2023 | Q4-CY2022 | Q3-CY2022 | Q2-CY2022 | Q1-CY2022 | Q4-CY2021 | Q3-CY2021 | Q2-CY2021 | Q1-CY2021 | Q4-CY2020 | Q3-CY2020 | Q2-CY2020 | Q1-CY2020 | Q4-CY2019 | Q3-CY2019 | Q2-CY2019 | Q1-CY2019 | Q4-CY2018 | Q3-CY2018 | Q2-CY2018 | Q1-CY2018 | Q4-CY2017 | Q3-CY2017 | Q2-CY2017 | Q1-CY2017 | Q4-CY2016 | Q3-CY2016 | Q2-CY2016 | Q1-CY2016 | Q4-CY2015 | Q3-CY2015 | Q2-CY2015 | Q1-CY2015 | Q4-CY2014 | Q3-CY2014 | Q2-CY2014 | Q1-CY2014 | Q4-CY2013 | |
| Balance Sheet Date | 2025-Jun-30 | 2025-Mar-31 | 2024-Dec-31 | 2024-Sep-30 | 2024-Jun-30 | 2024-Mar-31 | 2023-Dec-31 | 2023-Sep-30 | 2023-Jun-30 | 2023-Mar-31 | 2022-Dec-31 | 2022-Sep-30 | 2022-Jun-30 | 2022-Mar-31 | 2021-Dec-31 | 2021-Sep-30 | 2021-Mar-31 | ||||||||||||||||||||||||||||||||
| Fiscal Period | Q4-FY2025 | Q3-FY2025 | Q2-FY2025 | Q1-FY2025 | Q4-FY2024 | Q3-FY2024 | Q2-FY2024 | Q1-FY2024 | Q4-FY2023 | Q3-FY2023 | Q2-FY2023 | Q1-FY2023 | Q4-FY2022 | Q3-FY2022 | Q2-FY2022 | Q1-FY2021 | Q3-FY2020 | ||||||||||||||||||||||||||||||||
| Operating Cash Flow | (1,652,052$) | (1,601,902$) | (1,405,744$) | (1,689,989$) | (2,052,939$) | (1,497,378$) | (1,813,707$) | (2,726,825$) | (2,849,246$) | (2,190,545$) | (2,609,420$) | (2,033,922$) | (1,999,256$) | (1,461,263$) | (777,902$) | (828,904$) | (410,021$) | (134,956$) | (150,772$) | ||||||||||||||||||||||||||||||
| Investing Cash Flow | |||||||||||||||||||||||||||||||||||||||||||||||||
| Financing Cash Flow | 0$ | (116,664$) | 0$ | 0$ | (68,156$) | 0$ | (248,927$) | 6,699,148$ | 3,175,752$ | ||||||||||||||||||||||||||||||||||||||||
| End Cash Position | 11,627,849$ | 13,279,901$ | 14,998,467$ | 1,404,211$ | 3,094,200$ | 5,147,139$ | 6,644,517$ | 8,520,578$ | 11,247,403$ | 3,307,083$ | 3,024,980$ | ||||||||||||||||||||||||||||||||||||||
| Exchange Rate Effect | |||||||||||||||||||||||||||||||||||||||||||||||||
| Dividends Paid | |||||||||||||||||||||||||||||||||||||||||||||||||